Page URL:

Independent verification of multi-potent adult stem cells

29 January 2007
Appeared in BioNews 393

New research has been published confirming that 'multipotent' adult progenitor cells' (MAPCs), a type of adult stem cell, can repair and restore damaged blood systems in mice. Catherine Verfaillie and colleagues at the University of Minnesota first described these novel stem cells in 2002, but other teams have had difficulty in replicating the work. In a new paper published in the journal Experimental Medicine, Verfaillie has worked with a leading sceptic of the research, Dr Irving Weissman of Stanford University, to show that the cells can be grown in the laboratory and successfully transplanted into animals. Dr Weissman, who directs Stanford's Institute for Stem Cell Biology and Regenerative Medicine, rigorously examined the data and concluded, 'These experiments point to potential precursors of blood forming stem cell in an unexpected population of cultured cells'.

Usually adult stem cells are precursors to populations of particular cell types, for instance neural stem cells may be manipulated to grow into all types of nerve cell, or haematopoietic stem cells may be manipulated to form all different types of blood cell. MAPCs are more versatile than this as they are able to regenerate a range of cell and tissue types. In these latest experiments conducted by Dr Verfaillie, mice were irradiated to destroy their bone marrow and immune systems. The team isolated mesenchymal stem cells from mammalian bone marrow and grew them through at least 80 generations in the lab, they then used these cells to repopulate the damaged blood system. Whilst the results were good, the MAPCs were much less efficient at grafting into the bone marrow and producing blood than haematopoietic stem cells. This must be resolved before the scientists begin work on deriving human MAPCs for transplant. However, the team speculates that the research could one day be used to cure blood cancers and even grow entire new arteries in the lab.

This type of adult stem cell research has been welcomed by the White House, who wish to limit scientists' use of embryos. Verfaillie however, believes that stem cell research must progress on all levels including the use of embryonic cells. 'My research has been misused the whole time. There is a huge reason why we have to continue studying embryonic stem cells', Verfaillie said. She continued, 'I am pleased to see this science replicated at other research universities. Now there is further confirmation that the MAPCs could be a valid source of new therapies'. The next step for the researchers is to find out how the cells are reprogrammed to form blood and to understand why the MAPCs didn't contribute to more general repair in the irradiated mice. Although the experiment was designed to investigate blood formation specifically, Weissman was still disappointed that the MAPC cells did not join repair mechanisms in any other damaged tissues in the animals.

Adult stem cells can at least make blood
New Scientist |  25 January 2007
Blood stem cells make mouse bone marrow, brain cells
Scientific American |  15 January 2007
U Of MN Adult Stem Cell Research Shows Promise For Transplant Therapies
Medical News Today |  19 January 2007
28 April 2008 - by Evelyn Harvey 
Two men were the first subjects of a groundbreaking clinical research trial to establish the efficacy of treating patients with stem cells from their own bone marrow hours after a heart attack. The randomised controlled trial, the first to be supported by the UK Stem Cell Foundation...
4 February 2005 - by BioNews 
A new type of stem cell isolated from human bone marrow could have all the medical potential of embryonic stem (ES) cells, US researchers say. However, not all scientists are convinced of that the cells are as versatile as they appear to be, according to a report in the Washington...
29 April 2004 - by BioNews 
Patients with heart failure could one day be treated with injections of their own stem cells, according to new US trials that provide the 'first convincing evidence' that such an approach might work. Previous studies have produced conflicting results, and some researchers have questioned whether stem cell therapies for failing...
25 March 2004 - by BioNews 
Two new studies have cast further doubt on the ability of blood stem cells to turn into heart cells, even though several clinical trials based on this promising new treatment are currently underway. Researchers at Stanford University, California, and the University of Washington in Seattle have failed to duplicate the...
8 March 2004 - by BioNews 
The use of blood stem cells to treat heart attack patients shows promise, but can lead to complications, South Korean researchers say. A new study published in the Lancet shows that although the experimental treatment can help repair damaged heart tissue, it also causes side effects in many patients. As...
23 February 2004 - by BioNews 
American researchers have used cord blood cells to successfully treat several genetic diseases, and say they now have evidence that backs up their approach. The scientists, from Duke University Medical Centre, North Carolina, told a conference last week that they have been using stem cells taken from umbilical cord blood...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.